GlassScriptPhysician profile
Fouad Jaber
NPI 1679148126
$774.15
in general payments reported to CMS, 2019-2025
10 companies · $428 in 2025
The $428 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $98.00 · 2024: $248 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.46 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $168.44 | 2024-2025 | Entyvio, Gattex, Eohilia |
| Madrigal Pharmaceuticals | $111.11 | 2024-2025 | Rezdiffra, Resmetirom |
| Gilead Sciences, INC. | $98.00 | 2022 | |
| Boston Scientific Corporation | $49.60 | 2025 | Overstitch Endoscopic Suturing System, Orise |
| Janssen Biotech, INC. | $36.83 | 2025 | Tremfya |
| Intercept Pharmaceuticals, INC. | $35.85 | 2025 | |
| Medtronic, INC. | $28.53 | 2025 | Nexpowder |
| Genzyme Corporation | $24.21 | 2024 | |
| Ardelyx, INC. | $14.12 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fouad Jaber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.